MGRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mangoceuticals Inc (MGRX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of trading signals, and no significant catalysts make it a hold. The stock's technical indicators and pre-market price increase do not provide sufficient confidence for a long-term investment.
The MACD is positive but contracting, RSI is neutral at 28.916, and moving averages are converging. The pre-market price is $0.388, up 4.30%, but it remains below key resistance levels (R1: $0.635). The stock has a 40% chance to gain 3.88% in the next month, which is not compelling for long-term growth.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Gross margin also decreased slightly. No recent congress trading or influential figure activity.
In Q3 2025, revenue decreased significantly by 36.83% YoY to $84,246. Net income improved but remains negative at -$7,912,218. EPS dropped drastically by 95.35% YoY to -0.69, and gross margin declined slightly to 60.42%.
No analyst rating or price target changes available.
